The Senior Special Adviser to the President on Industrialisation at the African Development Bank, Prof. Banji ...

Throughout the world, an estimated 800 million people consider cassava root a staple part of their diet. This starchy tuber—also known as yuca, Brazilian arrowroot, and manioc—first originated in ...

Cassava Sciences has agreed to pay $40 million to resolve an investigation into claims it made misleading statements about phase 2b data on its Alzheimer’s disease drug candidate. The U.S ...

The SEC said that Cassava made misleading statements about a clinical trial of its Alzheimer’s disease drug. Cassava in the settlement neither confirmed nor denied the charges. Study data was ...

After hours: October 18 at 7:51 PM EDT Loading Chart for SAVA ...

PepsiCo (NASDAQ:PEP) confirmed on Tuesday that it struck a deal Siete for $1.2 billion. Siete Foods was founded in 2014 by ...

made in September 2020 about the results of the trial. "Cassava is pleased to put this matter behind us," CEO Richard Barry said in a separate statement. "We can now focus all of our attention on ...

The misleading statements were made in September 2020 about the results of a phase two clinical trial for Cassava's purported drug treatment for Alzheimer's, the SEC said. Cassava's shares dropped ...